Veterinary medicines European public assessment report (EPAR): ProZinc, insulin human, Status: Authorised
Human medicines European public assessment report (EPAR): Evusheld, tixagevimab,cilgavimab, Date of authorisation: 25/03/2022, Revision: 10, Status: Withdrawn
Veterinary medicines European public assessment report (EPAR): Profender, emodepside,praziquantel, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Procox, emodepside,toltrazuril, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Prevomax, maropitant, Status: Authorised
Leqembi
Refresher training webinar on post-authorisation procedure management in IRIS for marketing authorisation holders, Online, European Medicines Agency, Amsterdam, the Netherlands, from 30 September 2025, 10:00 (CEST) to 30 September 2025, 12:00 (CEST)
Quetiapine
Management Board - Outcome of written procedures finalised during the period from 29 June to 22 September 2025
Agenda - Medicine Shortages (SPOC) Working Party meeting on 14-15 October 2025